当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 2014年第1期
编号:13143337
血液透析患者中糖尿病对甲状旁腺激素的影响(2)
http://www.100md.com 2014年1月5日 赵永利 王凤丽 杨立志
第1页

    参见附件。

     [3]Buargub MA,Nabulsi MF,Shafeh TA.Prevalence and pattern of renal osteodystrophy in chronic hemodialysis patients:a cross sectional study of 103 patients.Saudi J Kidney Dis Transpl,2006,17(3):401-407.

    [4]Seino Y & Ishida H.Diabetic osteopenia.Pathophysiology and clinical aspects.Diabetes and Metabolism Reviews,1995(11):21-35.

    [5]McNair P,Madsbad S,Christiansen C,Christensen MS & Transbal I.Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin treated diabetic out-patients.Clinica Chimica Acta,1982(120):243-250.

    [6]Toshitsugu Sugmoto,Cynthia Ritter,Jeremiah Morrissey,et al.Effects of high concentrations of glucose on PTH secretion in parathyroid cells[J].Kidney Int,1990,37:1522-1527.

    [7]Reiichi Murakami,Shuichi Murakami,Rumi Tsushima,Chiyuki Ueda,KyokoMikami,Takanori Ebina,Ryuichiro Kumasaka,Norio Nakamura,Ken Okumura.Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy.Nephrol Dial Transplant,2007,10:1-6.

    [8]Rude RK,Oldhan SB,Sharp CF & Singer FR.Parathyroid hormone secretion in magnesium deficiency. Journal of Clinical Endocrinology and Metabolism,1978(47):800-806.

    [9]王笑云,陆卫平,赵秀芬.高磷对血管平滑肌骨钙素mRNA表达和钙沉积的影响[J].中华肾脏病杂志,2003,19(2):105-108.

您现在查看是摘要介绍页,详见PDF附件